Literature DB >> 23348768

ACMG Policy Statement. Risk categorization for oversight of laboratory-developed tests for inherited conditions.

Kristin G Monaghan1, Judith Benkendorf, Athena M Cherry, Susan J Gross, C Sue Richards, Vernon Reid Sutton, Michael S Watson.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23348768     DOI： 10.1038/gim.2012.178

Source DB:  PubMed          Journal:  Genet Med        ISSN： 1098-3600            Impact factor:   8.822


× No keyword cloud information.
  3 in total

1.  Developing context-specific next-generation sequencing policy.

Authors:  Margaret Ann Curnutte; Karen L Frumovitz; Juli M Bollinger; Robert M Cook-Deegan; Amy L McGuire; Mary A Majumder
Journal:  Nat Biotechnol       Date:  2016-05-06       Impact factor: 54.908

2.  Next-generation sequencing for constitutional variants in the clinical laboratory, 2021 revision: a technical standard of the American College of Medical Genetics and Genomics (ACMG).

Authors:  Catherine Rehder; Lora J H Bean; David Bick; Elizabeth Chao; Wendy Chung; Soma Das; Julianne O'Daniel; Heidi Rehm; Vandana Shashi; Lisa M Vincent
Journal:  Genet Med       Date:  2021-04-29       Impact factor: 8.822

3.  Risk categorization for oversight of laboratory-developed tests for inherited conditions: an updated position statement of the American College of Medical Genetics and Genomics (ACMG).

Authors:  Sarah T South; Michelle McClure; Caroline Astbury; Michael T Bashford; Judith Benkendorf; Edward D Esplin; Kristin G Monaghan; Devin Oglesbee; V Reid Sutton; Michael S Watson
Journal:  Genet Med       Date:  2020-03-04       Impact factor: 8.822
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.